We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Blog

Developing Therapies to Fight Cancer and Autoimmune Diseases
Developing Therapies to Fight Cancer and Autoimmune Diseases
Blog

We recently spoke to Alexis Peyroles, CEO at OSE Immunotherapeutics to hear more about the findings of their recent study, describing, for the first time ever, the in vivo mechanism of action of interleukin 7 receptor alpha (IL-7Rα) monoclonal antibodies, suggesting therapeutic efficacy in controlling chronic inflammation.

Read More

Developing Stem Cell Therapy Solutions for Liver Disease
Developing Stem Cell Therapy Solutions for Liver Disease
Blog

We spoke with Eric Schuur, President and CEO of HepaTx, to learn how the company hopes to develop regenerative medicine solutions for people with liver disease. Eric provides an overview of the steps involved in hepatocyte production and provides insights on the hurdles that need to be overcome, to get these stem cells from the lab to the clinic.

Read More

Sustainability Through Innovation
Sustainability Through Innovation
Blog

With growing pressure on labs to reduce waste and improve sustainability, we spoke to the Sustainability Forum at Agilent to learn more about what the company are doing to help their customers achieve their sustainability goals.

Read More

Making the Move to Continuous Bioprocessing
Making the Move to Continuous Bioprocessing
Blog

Bioprocessing has taken on many forms over the years. Efficiency and process economics are driving the bioprocessing industry forward, fueling a move from traditional stainless steel to single use – and now continuous.

Read More

Developing RNA Medicines for Rare Genetic Diseases
Developing RNA Medicines for Rare Genetic Diseases
Blog

There are approximately 7,000 known rare diseases, however, less than 6% of these have a treatment. It is estimated that between 25–35 million Americans live with a rare disease. The company ProQR is dedicated to developing new therapeutics for patients living with untreated rare diseases. We caught up with Daniel de Boer, Chief Executive Officer at ProQR to learn more about the company’s approach to finding new treatments for rare genetic diseases.

Read More

The Digital Solutions Offering Complete Control over Bioprocessing Workflows
The Digital Solutions Offering Complete Control over Bioprocessing Workflows
Blog

Robust data management is integral to both academic researchers and scientists in the pharmaceutical industry, especially for those working with bioprocessing workflows. In this blog, Thermo Fisher Scientific’s Karen Velardi explains how the introduction of digital science solutions to the modern lab is transforming bioprocessing workflows by providing scientists with full control over procedures, data integrity and compliance

Read More

Injectable Discogenic Cell Therapy Developed to Alleviate Back Pain
Say Hello to Regenerative Medicine and Goodbye to Back Pain
Blog

Degenerative disc diseases are debilitating, and treatment options are lacking. Three leaders from Discgenics explain how they are harnessing the restorative potential of cells native to the intervertebral disc to alleviate lower back pain.

Read More

A Move Towards Precise Management of Bacterial Infections
A Move Towards Precise Management of Bacterial Infections
Blog

Following the recent FDA approval of a procalcitonin assay, we spoke with a representative from Fujirebio Diagnostics, Inc. to learn how measuring this important biomarker will improve the healthcare landscape.

Read More

Supporting the Development of Regenerative Medicines
Supporting the Development of Regenerative Medicines
Blog

Regenerative medicine is a branch of translational research which focuses on methods to regrow, repair or replace human cells, tissues or organs. We recently spoke with Michael May, President & CEO of CCRM, an organization supporting the development of regenerative medicines and associated technologies to learn more about their latest projects and collaborations.

Read More

Developing Bispecific Antibodies
Developing Bispecific Antibodies
Blog

Bispecific antibodies (bsAbs) harness the specificities of two antibodies and combine them to simultaneously recognize different antigens or epitopes. This ‘two-target’ functionality has meant that interest in their use for therapeutic applications has increased considerably. We spoke to GenScript’s Liusong Yin, PhD, and Jie Ma, to learn more about bispecific antibodies and the associated challenges developing them.

Read More